Treating Shoulder Pain: Corticosteroid Injection vs. Phenol Injectio

Not Applicable

Recruiting

• Conditions: Osteoarthritis; Shoulder Pain; A02.835.583.032

• Registration Number: RBR-6vbgvqh
• Lead Sponsor: Gilson Carone Neto

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-20
• Last Update Posted: 29 May 2023
• Study Completion: 2023-10-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Male and female patients; over 18 years old; with pain in the acromioclavicular joint (for more than a month); with moderate or severe chronic joint pain (VAS equal to or greater than 4).

Exclusion Criteria

Patients with contraindications to the procedure: blood dyscrasia; refusal of the procedure; infection at the puncture site; patients with any other shoulder dysfunction that may confound the diagnosis such as advanced osteoarthritis of the glenohumeral joint, or adhesive capsulitis; patients with cognitive impairment or psychiatric disorder; allergic to lidocaine, methylprednisolone and phenol; pregnant women; patients with complete loss of joint space on ultrasound examination.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the efficacy of neurolysis with 5% phenol in the treatment of pain in patients with acromioclavicular joint pain compared with intra-articular corticosteroid injection.

Secondary Outcome Measures

Name	Time	Method
To verify if there is superiority of neurolysis over intra-articular corticosteroid injection to improve joint pain;Assess pain over a 6-month period, through the numerical verbal pain scale and ASES (American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form) questionnaire: pre-procedure, 1 hour after the procedure, after 1 week, 1 month, 3 and 6 months;